Electromed, Inc.
AMEX:ELMDMedical - Devices
+$0.43 today
- Market cap
- $191.27M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
Volume 0.05M
Average 0.06M
ELMD EBITDA Margin
EBITDA as a percentage of revenue.
Electromed, Inc.AMEX: ELMD
EBITDA Margin · Q3 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 22.4%
EBITDA Margin was 22.4% in Q3 FY2026, up 6.0 pp from a year earlier. On a trailing-twelve-month basis it was 20.6%, up 3.4 pp year over year. Over 3 fiscal years it widened by 9.2 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 20.4% for the fiscal year ending Jun 2026, up from 17.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 22.4%+1.3 pp QoQ
- Last fiscal yearJun 2025
- 17.9%+3.5 pp YoY
- LTMMar 2026
- 20.6%+3.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +6.0 pp | -0.2 pp | -6.2 pp |
| 1 year | +3.5 pp | +2.5 pp | -1.0 pp |
| 3 years | +9.2 pp | +5.6 pp | -3.6 pp |
| 5 years | -0.8 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 17.9%
- Year-over-year change
- +3.5pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 17.9% | +3.5pp |
| FY2024 | 2024-06-30 | 14.4% | +4.6pp |
| FY2023 | 2023-06-30 | 9.8% | +1.1pp |
| FY2022 | 2022-06-30 | 8.7% | -1.9pp |
| FY2021 | 2021-06-30 | 10.6% | — |
EBITDA Margin vs competitors
How ELMD compares with its peers on the latest reported figures
- ELMD's LTM Mar 2026 EBITDA Margin of 20.6% is the 2nd highest of the 6 companies compared; the peer median is 16.2%.
- Its year-over-year change of +3.4 pp is the 2nd highest of 6, against a peer median of +0.8 pp.
- Over three fiscal years its change of +9.2 pp compares with a peer median of +5.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 38.3% | +1.0 pp | +5.9 pp | |
| LTM Mar 2026 | 20.6% | +3.4 pp | +9.2 pp | |
| LTM Mar 2026 | 18.5% | +0.7 pp | +1.2 pp | |
| LTM Apr 2026 | 16.2% | -7.4 pp | -5.7 pp | |
| LTM Mar 2026 | 12.1% | +0.8 pp | +11.1 pp | |
| LTM Mar 2026 | -54.5% | +6.4 pp | +50.0 pp | |
| Peer median (excluding ELMD) | 16.2% | +0.8 pp | +5.9 pp | |
Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 35.76M | 41.66M | 48.07M | 54.72M | 64M |
| Cost of Revenue | 8.45M | 10.22M | 11.55M | 12.99M | 14.03M |
| Gross Profit | 27.31M | 31.44M | 36.52M | 41.73M | 49.97M |
| Gross Margin | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% |
| Research & Development | 1.72M | 1.36M | 916K | 656K | 996K |
| Selling, General & Admin | 22.44M | 27.11M | 31.6M | 34.49M | 39.1M |
| Operating Expenses | 24.17M | 28.47M | 32.51M | 35.15M | 40.1M |
| Depreciation & Amortization | 610K | 628K | 613K | 841K | 1.17M |
| EBITDA | 3.78M | 3.63M | 4.7M | 7.88M | 11.46M |
| EBITDA Margin | 10.6% | 8.7% | 9.8% | 14.4% | 17.9% |
| Operating Income | 3.14M | 2.97M | 4.01M | 6.58M | 9.87M |
| Operating Margin | 8.8% | 7.1% | 8.3% | 12.0% | 15.4% |
| Interest Income | 39K | 25K | 78K | 455K | 624K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 27K | 25K | 78K | 455K | 412K |
| Income Before Tax | 3.17M | 3M | 4.09M | 7.04M | 10.28M |
| Pre-Tax Margin | 8.9% | 7.2% | 8.5% | 12.9% | 16.1% |
| Income Tax Expense | 805K | 692K | 920K | 1.89M | 2.75M |
| Net Income | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M |
| Net Margin | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% |
| EPS (Basic) | 0.28 | 0.27 | 0.37 | 0.60 | 0.90 |
| EPS (Diluted) | 0.27 | 0.26 | 0.36 | 0.58 | 0.86 |
| Weighted Avg Shares | 8.57M | 8.47M | 8.46M | 8.56M | 8.33M |
| Weighted Avg Shares (Diluted) | 8.91M | 8.77M | 8.7M | 8.86M | 8.72M |
Electromed, Inc.
AMEX:ELMD
Intrinsic Alpha fair value
Locked
Current Price
$23.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.